Hahaha...call me dense, but I had a hard time understanding "what" was said. So, the "top-line" numbers were supposed to be released in 2014 and they postponed them until today and yet, I didn't hear the word "top-line" in the presentation. This is of course unless he never said that and it was someone one the board that said it. That happens alot. Again, still here, thesis has not changed, company moving forward quickly. I guess I was expecting (yes, bad thing to do) more info on how the test is going to be marketed, did they have any orders for it, is it not quite ready, etc. I am confused and wondering when revenue may begin to be generated. Again, I am not the brightest on this board and thats why I am asking questions. Am I the only one with these thoughts? So far all I am reading is "its all good". And perhaps it is. Just thinking out loud with my uneducated mind.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links